CD19-CART in the Treatment of R/R CD19 Positive Non-Hodgkin's Lymphoma

NCT04237428 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Hodgkin Lymphoma

Interventions

BIOLOGICAL: CD19 CAR-T cells infusion

Sponsor

PersonGen BioTherapeutics (Suzhou) Co., Ltd.

Collaborators

[object Object]